Our investigation was performed in the Drug Bank database and showed that some drugs, including Peroxisomal acyl-coenzyme A oxidase 1 and Methocarbamol, are designed for Aox1 and Tspan1, as therapeutic anti pancreatic cancer targets, respectively. The gene discussed is ACOX1; the disease is familial pancreatic carcinoma.